Glycosorb® ABO is pushing the boundaries in paediatric blood group incompatible heart transplantation
We have had the opportunity to interview Dr. Issitt, Senior Paediatric Perfusionist at Great Ormond Street Hospital (GOSH), London, and the full interview is scheduled to be published in our interim report for the first quarter, which will be released on May 23. In 2015, the perfusionist team and the transplant team at GOSH in London, incorporated Glycosorb® ABO into the cardiopulmonary bypass system in order to expand the donor pool and facilitate for more children to receive a heart transplant. GOSH has since published three articles[1,2,3]. The short-term data are excellent and have